Tyers Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Tyers Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$9K	Hold	960	–	–	﹤0.01%	990
2019 Q2	$10K	Buy	+960	New	+$10.2K	﹤0.01%	981
2019 Q1	–	Sell	-12,880	Closed	-$148K	–	995
2018 Q4	$148K	Sell	12,880 -5,648	-30%	-$70.2K	0.01%	741
2018 Q3	$314K	Buy	18,528 +8,896	+92%	+$135K	0.01%	626
2018 Q2	$137K	Buy	9,632 +7,232	+301%	+$120K	﹤0.01%	790
2018 Q1	$46K	Buy	+2,400	New	+$51.3K	﹤0.01%	934

Other funds holding SGMO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Tyers Asset Management's SGMO Position: Q3 2019 in Review

Tyers Asset Management held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q3 2019 at 960 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #990.

Tyers Asset Management first reported a position in SGMO in Q1 2018 and has held it in 6 quarters since. The position peaked at $314K in Q3 2018. 184 funds tracked by Wall St. Rank hold SGMO as of Q3 2019.

Tyers Asset Management held 960 shares of SANGAMO THERAPEUTICS INC worth $9K as of Q3 2019.
Tyers Asset Management left its SANGAMO THERAPEUTICS INC share count unchanged in Q3 2019.
SANGAMO THERAPEUTICS INC made up ﹤0.01% of Tyers Asset Management's portfolio in Q3 2019, its #990 holding.
Tyers Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2018 and has held it in 6 quarters since.
Tyers Asset Management's SANGAMO THERAPEUTICS INC position peaked at $314K in Q3 2018.
184 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.